Dr Joan Mutyoba

Joan Mutyoba is a medical doctor with graduate training in infectious diseases epidemiology and a PhD in Epidemiology & Public Health. Dr Mutyoba is currently an AfOx Visiting Fellow at the Big Data Institute, Nuffield Department of Population Health, University of Oxford, as part of the Africa Oxford Visiting Fellowship Programme.

Dr. Joan Nankya Mutyoba is a Senior Lecturer at Makerere University and leads the Department of Epidemiology & Biostatistics at the School of Public Health. She was a Uganda Co-Investigator on a multi-site population-based study that aimed to assess the prevalence and risk factors of chronic non-communicable diseases (NCDs) in Uganda, Tanzania, Nigeria, and South Africa. The study also evaluated the feasibility of establishing long-term, prospective cohorts to study the etiology, risk factors, and socio-cultural issues related to chronic NCDs among indigenous Africans.

Joan's research has focused on HIV and hepatocellular carcinoma in Uganda. Specifically, she studied viral hepatitis B among HIV infected and uninfected pregnant women in Uganda. This research was funded by NIH under the U54 Program on SSA collaborative HIV and cancer consortia. Currently, Joan is a co-Investigator on two viral hepatitis studies. The first study aims to determine the prevalence of hepatitis C, HIV co-infection, and related factors among blood donors in Uganda. The second study aims to evaluate the feasibility and cost-effectiveness of integrating HIV and viral hepatitis B care within public health care facilities in Uganda.

Joan is also a co-investigator on a U-54 SSA grant on HIV-associated malignancies in sub-Saharan Africa. She is a Principal Investigator on a study titled “Models to link and retain hepatitis B infected persons into long-term care in a high HBV burden region of Uganda”. Additionally, Joan has served as a member of the Safety Review Board of several international clinical studies of HIV vaccines conducted by the International AIDS Vaccine Initiative.

While at Oxford, Dr. Mutyoba will be working on a project that focuses on developing models to link and retain hepatitis B-infected patients in long-term care in a high-burden region of Uganda.

• Mutyoba, J.N., Wandera, C., Ejalu, D. et al. Feasibility and acceptability of integrating hepatitis B care into routine HIV services: a qualitative study among health care providers and patients in West Nile region, Uganda. BMC Health Serv Res 23, 59 (2023). https://doi.org/10.1186/s12913-022-08924-0
• Nankya-Mutyoba, J., Ejalu, D., Wandera, C. et al. A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: the ‘2for1’ project. BMC Med Educ 22, 297 (2022). https://doi.org/10.1186/s12909-022- 03329-3
• Ejalu DL, Mutyoba JN, Wandera C, et al. Integrating hepatitis B care and treatment with existing HIV services is possible: cost of integrated HIV and hepatitis B treatment in a low-resource setting: a cross-sectional, hospital based cost-minimisation assessment. BMJ Open 2022;12:e058722. doi:10.1136/ bmjopen-2021-058722
• Hepatitis C in Uganda: Identification of infected blood donors for micro-elimination. J Nankya-Mutyoba et al. Journal of Virus eradication; Volume 7, Issue 2, June 2021, 100041
• Nsibirwa, S., Anguzu, G., Kamukama, S., Ocama P. and Nankya Mutyoba J. Herbal medicine use among patients with viral and non-viral Hepatitis in Uganda: prevalence, patterns and related factors. BMC Complement Med Ther 20, 169 (2020). https://doi.org/10.1186/s12906-020-02959-8